Home › Funds › PRIMECAP MANAGEMENT CO/CA/ › AZN

PRIMECAP MANAGEMENT CO/CA/ position in AZN

ASTRAZENECA PLC · Health Care

PRIMECAP MANAGEMENT CO/CA/ reported holding 18,108,546 shares of AZN (ASTRAZENECA PLC) in its Q3 2026 13F filing — a position valued at US$2.92B, representing 1.81% of its reported portfolio and ranking #10 among its reported holdings. PRIMECAP MANAGEMENT CO/CA/ has disclosed AZN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)18.11M sh
Reported value held$2.92B
Portfolio Weight1.81%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PRIMECAP MANAGEMENT CO/CA/'s AZN position evolved

PRIMECAP MANAGEMENT CO/CA/ first disclosed a stake in AZN in Q3 2023 at 43,889,365 shares (US$2.97B). The position peaked in Q1 2026 at 18,213,708 shares, worth US$3.59B. Across 13 filings, PRIMECAP MANAGEMENT CO/CA/ increased the stake 1 time(s), trimmed it 9 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 18,108,546 shares valued at US$2.92B. Notable position changes include a 51% trim in Q1 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 43.89M $2.97B New
Q4 2023 42.99M $2.90B Reduce
Q1 2024 42.95M $2.91B Hold
Q2 2024 42.60M $3.32B Reduce
Q3 2024 41.98M $3.27B Reduce
Q4 2024 41.02M $2.69B Reduce
Q1 2025 40.66M $2.99B Reduce
Q2 2025 41.20M $2.88B Add
Q3 2025 39.86M $3.06B Reduce
Q4 2025 36.92M $3.39B Reduce
Q1 2026 18.21M $3.59B Reduce
Q2 2026 18.10M $3.43B Reduce
Q3 2026 18.11M $2.92B Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 64 other funds we track also report a position in AZN — the largest reported positions include INVESTOR AB (US$9.78B), Norges Bank Investment Management (US$6.33B), Capital World Investors (US$5.63B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has PRIMECAP MANAGEMENT CO/CA/ held AZN?

PRIMECAP MANAGEMENT CO/CA/ has disclosed AZN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PRIMECAP MANAGEMENT CO/CA/'s current position in AZN?

As of Q3 2026, PRIMECAP MANAGEMENT CO/CA/ holds 18.11M shares of AZN (ASTRAZENECA PLC), valued at $2.92B, representing 1.81% of its reported portfolio and ranking #10.

Has PRIMECAP MANAGEMENT CO/CA/ been buying or selling AZN?

In the latest 13F filing (Q3 2026), PRIMECAP MANAGEMENT CO/CA/ held unchanged its position in AZN. The position peaked in Q1 2026 at 18.21M shares.

Which other funds hold AZN?

Other major institutional holders of AZN include INVESTOR AB, Norges Bank Investment Management, Capital World Investors, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.